No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk
- PMID: 19435861
- PMCID: PMC2770800
- DOI: 10.1158/1055-9965.EPI-09-0244
No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk
Figures
References
-
- Curry TE, Jr, Osteen KG. The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle. Endocr Rev. 2003;24:428–65. - PubMed
-
- Hudelist G, Lass H, Keckstein J, et al. Interleukin 1{alpha} and tissue-lytic matrix metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis. Hum Reprod. 2005;20:1695–1701. - PubMed
-
- Hudelist G, Keckstein J, Czerwenka K, et al. Estrogen receptor [beta] and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertility and Sterility. 2005;84:1249–56. - PubMed
-
- Uzan C, Cortez A, Dufournet C, Fauvet R, Siffroi JP, Darai E. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2. Virchows Arch. 2004;445:603–9. - PubMed
-
- Gilabert-Estelles J, Estelles A, Gilabert J, et al. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod. 2003;18:1516–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
